Related Articles |
[Clinical trials and perspectives of radiotherapy for uterine endometrial cancers].
Bull Cancer. 2017 Oct 31;:
Authors: Chargari C, Maroun P, Lazarescu I, Haie-Meder C
Abstract
The adjuvant management of uterine endometrial cancer has been studied in many randomized trials, leading to define postoperative therapeutic indications, depending on the risk factors for relapse, and on the expected benefit in terms of locoregional control and survival. The potential toxicity of treatments should be also considered. We review the available literature that yielded to guidelines that were recently published, on behalf of European societies, and we highlight the perspectives on ongoing studies, aimed at better defining the place and type of adjuvant treatment.
PMID: 29100604 [PubMed - as supplied by publisher]
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2ywJpy3
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου